History, aetiology, and symptomatology of schizophrenia

Psychiatry

Volumn 7, Issue 10, 2008, Pages 404-409

  Tsoi, Daniel T Y ^a   Hunter, Michael D ^a   Woodruff, Peter W R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

aetiology; biopsychosocial model; history; negative symptoms; positive symptoms; schizophrenia

Indexed keywords

BIOLOGICAL FACTOR; NEUROTRANSMITTER RECEPTOR;

BRAIN DEVELOPMENT; CANNABIS ADDICTION; COGNITIVE DEFECT; EMOTIONALITY; ENVIRONMENTAL STRESS; HEREDITY; HISTORY OF MEDICINE; LIFE EVENT; MENTAL STRESS; NEUROANATOMY; NEUROCHEMISTRY; NEUROIMAGING; OUTCOME ASSESSMENT; PATHOLOGY; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SCHIZOPHRENIA; SOCIAL ASPECT; SYMPTOMATOLOGY;

EID: 53149122119     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mppsy.2008.07.010     Document Type: Review

References (22)

1. Kraepelin E. Psychiatrie. 5th edn. (1896), Barth, Leipzig
2. Craddock N., and Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186 (2005) 364-366
3. Craddock N., and Owen M.J. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6 (2007) 20-27
4. Shih R.A., Belmonte P.L., and Zandi P.P. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 16 (2004) 260-283
5. Harrison P.J., and Owen M.J. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361 (2003) 417-419
6. Ross C.A., Margolis R.L., Reading S.A.J., Pletnikov M., and Coyle J.T. Neurobiology of schizophrenia. Neuron 52 (2006) 139-153
7. Owen M.J., Craddock N., and Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 33 (2007) 905-911
8. Abi-Dargham A., and Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9 (2003) 404-416
9. Andreasen N.C. A unitary model of schizophrenia: Bleuler's 'fragmented phrene' as schizencephaly. Arch Gen Psychiatry 56 (1999) 781-787
10. Abi-Dargham A. Alterations of serotonin transmission in schizophrenia. Int Rev Neurobiol 78 (2007) 133-164
11. Stone J.M., Morrison P.D., and Pilowsky L.S. Glutamate and dopamine dysregulation in schizophrenia - a synthesis and selective review. J Psychopharmacol 21 (2007) 440-452
12. Sprong M., Schothorst P., Vos E., Hox J., and Van Engeland H. Theory of mind in schizophrenia: meta-analysis. Br J Psychiatry 191 (2007) 5-13
13. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., and Cooper J.E. Schizophrenia: manifestations, incidence, and course in different cultures - a World Health Organization ten-country study. Psychol Med Monogr Suppl 20 (1992) 1-97
14. Di Forti M., Morrison P.D., Butt A., and Murray R.M. Cannabis use and psychiatric and cognitive disorders: the chicken or the egg?. Curr Opin Psychiatry 20 (2007) 228-234
15. Nuechterlein K.H., and Dawson M.E. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 10 (1984) 300-312
16. Cooper J.E., Kendell R.E., Gurland B.J., et al. Psychiatric diagnoses in New York and London. Maudsley Monograph 20 (1972), Oxford University Press, London
17. Crow T.J., Ferrier I.N., and Johnstone E.C. The two-syndrome concept and neuroendocrinology of schizophrenia. Psychiatr Clin North Am 9 (1986) 99-113
18. Liddle P.F., Friston K.J., Frith C.D., et al. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160 (1992) 179-186
19. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 153 (1996) 321-330
20. Schneider K. Clinical psychopathology (1959), Grune and Stratton, New York
21. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) (1983), University of Iowa, Iowa
22. Mortimer A., and Spence S. Managing negative symptoms of schizophrenia (2001), Science Press, London